SOLICITATION NOTICE
A -- NIAID HIV/AIDS Scientific and Operations Support
- Notice Date
- 12/12/2014
- Notice Type
- Presolicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 5601 Fishers Lane, 3rd Floor, MSC 9821, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- RFP-NIAID-DAIDS-NIHAI2015030
- Archive Date
- 1/13/2015
- Point of Contact
- Robert J. Corno, Phone: 2406695151, John Manouelian, Phone: 2406695152
- E-Mail Address
-
robert.corno@nih.gov, manouelj@mail.nih.gov
(robert.corno@nih.gov, manouelj@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Introduction The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious diseases. The Acquired Immunodeficiency Syndrome (AIDS) pandemic is growing worldwide at an alarming rate and has disproportionately affected the health, economic development and political stability of many of the world's poorest and most vulnerable populations. To combat this global threat and to prevent the spread of HIV (Human Immunodeficiency Virus) infection, the NIAID supports biomedical research to increase the basic knowledge of the pathogenesis, natural history and transmission of HIV disease, and to evaluate new and improved approaches for the detection, treatment and prevention of HIV infection and its complications. NIAID accomplishes this through planning, implementing, managing and evaluating programs in the following: (1) fundamental basic research; (2) discovery and development of therapies for HIV infection and its complications; and (3) discovery and development of vaccines and other prevention strategies. The significant majority of these activities are housed in NIAID's Division of AIDS (DAIDS) with limited support provided to other organizational components of NIAID. The NIAID HIV/AIDS programs must be built with flexibility and coordinate across NIAID with other organizations, in order to permit rapid, efficient and scalable responses to emerging scientific and clinical opportunities. A signification portion of the work carried out by DAIDS is the oversight of the design, implementation, conduct and oversight of clinical trials and clinical studies supported through grants, contracts and interagency agreements. This includes NIAID-sponsored Phase I, II, III, IV and post-marketing trials of HIV therapeutic, vaccine and prevention clinical research. NIAID currently supports clinical research efforts through large clinical networks, individual single or multi-site grants, and partnerships with other Federal and non-Federal agencies. NIAID is currently supporting approximately 400 trials related to HIV and AIDS in various stages. These trials range from 10 to 6,000 participants and are conducted in more than 40 countries. Approximately half of the countries are resource poor. Description The Division of AIDS currently supports a contract for NIAID HIV/AIDS Scientific and Operations Support" under contract number HHSN272200800014C with Henry M. Jackson Foundation (HJF). The purpose of the contract is to provide scientific, technical and operational expertise for NIAID HIV and AIDS research, and particularly clinical research activities that are conducted as part of grant and contract awards. The scope of activities include: (1) Clinical Research Support; (2) Program Operations Support; (3) Communications Support; (4) Conflict of Interest Mitigation, Non-Disclosure and Confidentiality Plan; (5) Project Management; and (6) Final Transition. The Contractor provides critical support in areas such as laboratory monitoring, assay development, scientific and medical expertise, clinical site training, clinical trial planning and evaluation, clinical trial pharmacy support and oversight, clinical site monitoring, support for clinical trials' Data Safety and Monitoring Boards (DSMBs), clinical trial safety reporting of Adverse Events to the Food and Drug Administration (FDA), etc. The purpose of this follow-on extension is to continue to provide scientific, technical and operational expertise for NIAID DAIDS HIV and AIDS research and particularly clinical research activities that are conducted as part of grant and contract awards. The scope of activities included in the extension related to this notice are only those functions of the original contract that are deemed as critical/essential. The NIAID intends to negotiate, under authority of FAR 6.302-1 and HHSAR 306.302-1, on a sole source basis, with HJF to extend the existing contract period of performance for a six month period from March 1, 2015 through August 31, 2015, and to include an option to Extend Services to allow extension of the contract for an additional 6 month period from September 1, 2015 through February 29, 2016. No other source is able to provide these critical/essential services beginning on March 1, 2015 without causing unacceptable delays to the Government in fulfilling the agency's requirements. This notice of intent is not a request for competitive proposals. However, responsible sources may express their interest by submitting a capability statement. All capability statements received within fifteen days from the date of the publication of this notice will be considered by the Government. A determination by the Government not to compete this proposed contract action based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. This proposed acquisition was previously advertised under a Research and Development Sources Sought Notice that was posted in the Federal Business Opportunities on November 12, 2014 as notice number HHS-NIH-NIAID-RDSS-15-NIHAI2015130.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIAID/RFP-NIAID-DAIDS-NIHAI2015030/listing.html)
- Place of Performance
- Address: 5601 Fishers Lane, Bethesda, Maryland, 20892-9821, United States
- Zip Code: 20892-9821
- Zip Code: 20892-9821
- Record
- SN03595362-W 20141214/141212234729-74f18e3978186a218275e0ebb5160196 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |